MCRB - Seres Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5284.05M
Enterprise Value 3197.41M
Trailing P/E N/A
Forward P/E 1-3.89
PEG Ratio (5 yr expected) 10.03
Price/Sales (ttm)10.05
Price/Book (mrq)N/A
Enterprise Value/Revenue 36.98
Enterprise Value/EBITDA 6-2.14

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-354.77%

Management Effectiveness

Return on Assets (ttm)-40.44%
Return on Equity (ttm)-1,563.81%

Income Statement

Revenue (ttm)28.27M
Revenue Per Share (ttm)0.69
Quarterly Revenue Growth (yoy)247.80%
Gross Profit (ttm)-67.69M
EBITDA -92.42M
Net Income Avi to Common (ttm)-98.94M
Diluted EPS (ttm)-2.43
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)85.82M
Total Cash Per Share (mrq)2.09
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.20
Book Value Per Share (mrq)-1.17

Cash Flow Statement

Operating Cash Flow (ttm)-62.85M
Levered Free Cash Flow (ttm)-31.45M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.16
52-Week Change 3-10.39%
S&P500 52-Week Change 310.27%
52 Week High 39.75
52 Week Low 34.42
50-Day Moving Average 36.54
200-Day Moving Average 36.54

Share Statistics

Avg Vol (3 month) 3368.99k
Avg Vol (10 day) 398.04k
Shares Outstanding 541.05M
Float 20.97M
% Held by Insiders 117.50%
% Held by Institutions 177.62%
Shares Short (Mar 29, 2019) 45.18M
Short Ratio (Mar 29, 2019) 46.68
Short % of Float (Mar 29, 2019) 436.14%
Short % of Shares Outstanding (Mar 29, 2019) 412.61%
Shares Short (prior month Feb 28, 2019) 43.97M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A